Product Information
FAMCICLOVIR 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4425 per EA under NDC 64980035003. Its NADAC has been published 282 times since May 12, 2021.
FDA first approved this application on Mar 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980035003
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMCICLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA091114FDA Approved
3/21/2011
TE Code
AB
On Market Since
3/21/2011
Pharmacological Classes
Price Statistics
The NADAC for FAMCICLOVIR 250 MG TABLET has been published 282 times since May 12, 2021, and over the history we have for it it has declined 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4425 per EA |
|---|---|
| All-time high | $0.5643 (Jun 15, 2022) |
| All-time low | $0.3036 (Nov 20, 2024) |
| 52-week high | $0.4425 |
| 52-week low | $0.3980 |
| Median price | $0.4193 |
| Average price | $0.4314 |
| Largest weekly change | +34.3% (Dec 22, 2021) |
| Weeks tracked | 282 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famciclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMCICLOVIR 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FAMCICLOVIR 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.4425 per EA (NDC 64980035003), effective Sep 30, 2026.
How has the price of FAMCICLOVIR 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for FAMCICLOVIR 250 MG TABLET has declined 14.0%. It has been tracked across 282 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for FAMCICLOVIR 250 MG TABLET?
Since May 12, 2021, the NADAC for FAMCICLOVIR 250 MG TABLET has ranged from a low of $0.3036 (Nov 20, 2024) to a high of $0.5643 (Jun 15, 2022), with a median of $0.4193 per EA.
Are there cheaper alternatives to FAMCICLOVIR 250 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FAMCICLOVIR 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FAMCICLOVIR 250 MG TABLET?
FAMCICLOVIR 250 MG TABLET (NDC 64980035003) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.